PSNL.NASDAQPersonalis, INC

SCHEDULE 13G/A: ARK Investment Management Discloses 9.59% Stake in Personalis, Inc.

Sentiment:

Beneficial Ownership Report


ARK Investment Management LLC has reported a 9.59% beneficial ownership stake in Personalis, Inc., holding 6,775,435 shares of common stock as of December 31, 2024.

Summary

  • ARK Investment Management LLC, an investment adviser, has filed an Amendment No. 6 to Schedule 13G, disclosing its beneficial ownership in Personalis, Inc.
  • As of December 31, 2024, ARK Investment Management LLC beneficially owns 6,775,435 shares of Personalis, Inc. Common Stock.
  • This ownership represents 9.59% of the class of securities.
  • ARK Investment Management LLC holds sole voting power and sole dispositive power over all 6,775,435 shares.
  • The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing disclosing beneficial ownership. It does not contain positive or negative operational news about the company, but rather a factual report of an investment stake. The presence of a significant institutional investor could be seen as mildly positive by some, but the filing itself is neutral.

Positives

  • A significant institutional investor, ARK Investment Management LLC, holds a substantial 9.59% stake in Personalis, Inc., indicating confidence or strategic interest in the company.
  • ARK Investment Management LLC has sole voting and dispositive power over its shares, suggesting direct control over its investment decisions regarding Personalis, Inc.

Future Outlook

NA

Industry Context

This filing indicates a significant investment by a prominent asset manager, ARK Investment Management LLC, in Personalis, Inc., a company likely operating in the genomics, diagnostics, or precision medicine sector, given its name. Such investments by specialized funds can signal perceived growth potential within the biotech or healthcare technology industry.

Stakeholder Impact

  • Shareholders: The disclosure of a significant stake by a prominent institutional investor like ARK Investment Management LLC may influence investor perception and potentially share price, signaling institutional confidence or interest in Personalis, Inc.

Key Dates

DateDescription
12/31/2024Date of event which requires filing of this statement (beneficial ownership calculation date).
02/14/2025Date of signature for the Schedule 13G filing.

Keywords

Personalis Inc., ARK Investment Management LLC, Schedule 13G, Beneficial Ownership, Common Stock, Investment Adviser, Institutional Investor, Equity Stake

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.